166 related articles for article (PubMed ID: 19359524)
21. Differential usage of class II transactivator promoters PI and PIV during inflammation and injury in kidney.
Takeuchi O; Sims TN; Takei Y; Ramassar V; Famulski KS; Halloran PF
J Am Soc Nephrol; 2003 Nov; 14(11):2823-32. PubMed ID: 14569092
[TBL] [Abstract][Full Text] [Related]
22. Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases.
Yau AC; Piehl F; Olsson T; Holmdahl R
Immunology; 2017 Apr; 150(4):408-417. PubMed ID: 27861821
[TBL] [Abstract][Full Text] [Related]
23. 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter.
Adamski J; Ma Z; Nozell S; Benveniste EN
Mol Endocrinol; 2004 Aug; 18(8):1963-74. PubMed ID: 15143155
[TBL] [Abstract][Full Text] [Related]
24. Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene.
Waldburger JM; Suter T; Fontana A; Acha-Orbea H; Reith W
J Exp Med; 2001 Aug; 194(4):393-406. PubMed ID: 11514597
[TBL] [Abstract][Full Text] [Related]
25. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
[TBL] [Abstract][Full Text] [Related]
26. Sjögren's syndome and extragonadal sex steroid formation: a clue to a better disease control?
Konttinen YT; Stegajev V; Al-Samadi A; Porola P; Hietanen J; Ainola M
J Steroid Biochem Mol Biol; 2015 Jan; 145():237-44. PubMed ID: 25158020
[TBL] [Abstract][Full Text] [Related]
27. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA.
Lüder CG; Lang C; Giraldo-Velasquez M; Algner M; Gerdes J; Gross U
J Neuroimmunol; 2003 Jan; 134(1-2):12-24. PubMed ID: 12507768
[TBL] [Abstract][Full Text] [Related]
28. Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats.
Li WM; Liu W; Gao C; Zhou BG
Immunol Cell Biol; 2006 Jun; 84(3):274-80. PubMed ID: 16509827
[TBL] [Abstract][Full Text] [Related]
29. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapeutic targets in estrogen deficiency-dependent Sjögren's syndrome-related manifestations.
Arakaki R; Ishimaru N; Hayashi Y
Immunotherapy; 2010 May; 2(3):339-46. PubMed ID: 20635899
[TBL] [Abstract][Full Text] [Related]
31. Protein kinase C delta stimulates antigen presentation by Class II MHC in murine dendritic cells.
Majewski M; Bose TO; Sillé FC; Pollington AM; Fiebiger E; Boes M
Int Immunol; 2007 Jun; 19(6):719-32. PubMed ID: 17446207
[TBL] [Abstract][Full Text] [Related]
32. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells.
LeibundGut-Landmann S; Waldburger JM; Reis e Sousa C; Acha-Orbea H; Reith W
Nat Immunol; 2004 Sep; 5(9):899-908. PubMed ID: 15322541
[TBL] [Abstract][Full Text] [Related]
33. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome.
Fox RI; Bumol T; Fantozzi R; Bone R; Schreiber R
Arthritis Rheum; 1986 Sep; 29(9):1105-11. PubMed ID: 3092835
[TBL] [Abstract][Full Text] [Related]
34. Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation.
Waeckerle-Men Y; Starke A; Wahl PR; Wüthrich RP
Kidney Blood Press Res; 2007; 30(6):421-9. PubMed ID: 17975322
[TBL] [Abstract][Full Text] [Related]
35. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
[TBL] [Abstract][Full Text] [Related]
36. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha.
Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U
Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104
[TBL] [Abstract][Full Text] [Related]
37. p38 mitogen-activated protein kinase and nuclear factor-κB facilitate CD40-mediated salivary epithelial cell death.
Ping L; Ogawa N; Zhang Y; Sugai S; Masaki Y; Weiguo X
J Rheumatol; 2012 Jun; 39(6):1256-64. PubMed ID: 22505709
[TBL] [Abstract][Full Text] [Related]
38. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.
Chang CH; Guerder S; Hong SC; van Ewijk W; Flavell RA
Immunity; 1996 Feb; 4(2):167-78. PubMed ID: 8624807
[TBL] [Abstract][Full Text] [Related]
39. In vivo class II transactivator expression in mice is induced by a non-interferon-gamma mechanism in response to local injury.
Sims TN; Goes NB; Ramassar V; Urmson J; Halloran PF
Transplantation; 1997 Dec; 64(12):1657-64. PubMed ID: 9422398
[TBL] [Abstract][Full Text] [Related]
40. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]